Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 317 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
Obesity
N/A
Interventional 164 participants sought
Hartford HealthCare — Hartford, Connecticut (25.4 mi)
· Sponsor: Hartford Hospital
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
Hemiplegia, Cerebral Palsy
N/A
Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (25.9 mi)
· Sponsor: University of Connecticut
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Hartford HealthCare Cancer Institute — Hartford, Connecticut (25.4 mi)
· Sponsor: Kura Oncology, Inc.
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Giselle Sholler
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Elixia MA, LLC — Springfield, Massachusetts (2.8 mi)
· Sponsor: Teikoku Pharma USA, Inc.
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Hoffmann-La Roche
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: NRG Oncology
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: SWOG Cancer Research Network
Burning Mouth Syndrome: Symptoms and Management
Burning Mouth Syndrome
EARLY/Phase 1
Interventional 50 participants sought
UMass Amherst — Amherst, Massachusetts (17.4 mi)
· Sponsor: University of Massachusetts, Amherst
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Metastatic Ewing Sarcoma
Phase 1
Interventional 15 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: American Society of Clinical Oncology
A Study to Assess Growth in Children With Idiopathic Short Stature
Idiopathic Short Stature
N/A
Observational 300 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: BioMarin Pharmaceutical
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Mercy Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
N/A
Interventional 600 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: Medtronic Cardiovascular
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Hartford, Connecticut (25.4 mi)
· Sponsor: Medtronic
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Smilow Cancer Hospital at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
A Type I Hybrid Effectiveness-Implementation Trial of MIO
Substance Use Disorder
N/A
Interventional 200 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: Baystate Medical Center
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Mercy Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
HPV-Related Squamous Cell Carcinoma
Phase 3
Interventional 291 participants sought
Hartford Healthcare (Data Collection Only) — Hartford, Connecticut (25.4 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center